Farhad Shahi - Breast Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran
Mehrzad Mirzania - Department of Hematology & Medical Oncology, Tehran University of Medical Sciences, Tehran, Iran
Mahdi Aghili - Radiation Oncology Research Center ,Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran
Mohammadreza Dabiri - Department of Hematology & Medical Oncology, Tehran University of Medical Sciences, Tehran, Iran
Sharareh Seifi - Department of Hematology & Medical Oncology, Shahid Beheshti University of Medical Sciences, Tehran, Iran-Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases(NRITLD), Shahid Beheshti University of Me
Alireza Bary - Department of Hematology & Medical Oncology, Mashhad University of Medical Sciences, Mashhad, Iran

Background: In March ۲۰۲۰, the World Health Organization declared thenovel COVID-۱۹ infection a pandemic. Among high-risk patients infected by thevirus, breast cancer patients are vulnerable to present more severe infections. Iranis among the countries with a high incidence of COVID-۱۹ , and most of theroutine activities of medical centers are affected by the epidemic disease. Thus,there is a need to make some modifications to international protocols for dealingwith breast cancer in the affected countries.Methods: The headings of breast cancer management protocols have beendiscussed among the university-affiliated professors in different disciplinesinvolved in breast cancer management. The discussions were done through a“WhatsApp” group considering the tiles and the latest news about COVID-۱۹.Under each title, we provide the consensus of all members in the relateddisciplines.Recommendations and Conclusion: In each specialty, all members agreed tochoose minimal intervention. The modifications aim to reduce the workload of themedical centers as well as to provide the least interface of the patients with themedical centers. The members know that some recommendations may interferewith the routine best-practice recommendations and decrease the quality measuresin the patient's outcome. Therefore, these recommendations are valid just inepidemic COVID-۱۹ situation in the country.

Coronavirus breast cancer guidelines COVID-۱۹